27-Oct-2026 13:34:44
Acutaas Chemicals Shares Surge 11% After Raising FY27 Revenue and Margin Guidance on Strong Q2 Performance
Acutaas Chemicals reported a 42.7% year-on-year rise in Q2 FY27 revenue to ₹436.90 crore, driven by strong demand for pharmaceutical intermediates, which offset softer specialty chemicals performance. The company upgraded its FY27 revenue growth guidance to around 30%, from 25% earlier, and raised its EBITDA margin target to 38–40%. Acutaas also inaugurated its South Korea semiconductor chemicals facility ahead of schedule, targeting high-purity chemicals used in photoresists, etching and semiconductor packaging. Management cited a robust order pipeline and improved revenue visibility.